Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THR-184 for Prevention of CSA-AKI
NCT01830920Phase 2Completed
- Sponsor
- Thrasos Therapeutics
- Start
- May 2013
- Primary completion
- Sep 2015
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of THR-184 in acute kidney injury (AKI), sponsored by Thrasos Therapeutics. Started May 2013; status: completed.
02
Drugs
THR-184
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01830920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01830920.